Effectiveness of nonadjuvanted monovalent influenza A(H1N1) pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: Case-control study of children and adults at 10 US influenza surveillance network sites

10Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

During 2009-2010, we examined 217 patients hospitalized with laboratory-confirmed pandemic influenza in 9 Influenza Hospitalization Surveillance Network sites and 413 age-and community-matched controls and found that a single dose of monovalent nonadjuvanted influenza A(H1N1)pdm09 vaccine was 50% (95% confidence interval, 13%-71%) effective in preventing hospitalization associated with A(H1N1) pdm09 virus infection. © The Author 2013.

Cite

CITATION STYLE

APA

Thompson, M. G., Sokolow, L. Z., Almendares, O., Openo, K., Farley, M. M., Meek, J., … Shay, D. K. (2013). Effectiveness of nonadjuvanted monovalent influenza A(H1N1) pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: Case-control study of children and adults at 10 US influenza surveillance network sites. Clinical Infectious Diseases, 57(11), 1587–1592. https://doi.org/10.1093/cid/cit551

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free